Full text
Earnings transcript
Read the complete earnings call transcript.
ALGN
Align Technology, Inc.
$170.6
-2.13
(-1.23%)
Delayed data
| Exchange: | NASDAQ |
| Market Cap: | 12.241B |
| Shares Outstanding: | 4.218M |
About The Company
| Sector: | Healthcare | |||||
| Industry: | Medical – Devices | |||||
| CEO: | Joseph Hogan | |||||
| Full Time Employees: | 21200 | |||||
| Address: |
| |||||
| Website: | https://www.aligntech.com |
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment’s non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient’s historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 3,862,260 | 3,999,012 | 4,034,964 |
| Gross Profit | 2,706,863 | 2,799,159 | 2,756,897 |
| EBITDA | 799,055 | 816,798 | 765,874.955 |
| Operating Income | 643,338 | 607,628 | 616,216 |
| Net Income | 445,053 | 421,362 | 410,351 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 6,083,877 | 6,214,600 | 6,233,693 |
| Total Liabilities | 2,453,388 | 2,362,615 | 2,184,546 |
| Total Stockholders Equity | 3,630,489 | 3,851,985 | 4,049,147 |
| Total Debt | 126,619 | 119,277 | 82,507 |
| Cash and Cash Equivalents | 937,438 | 1,043,887 | 1,094,908 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 785,776 | 738,231 | 593,223 |
| Capital Expenditure | -177,716 | -115,580 | 0 |
| Free Cash Flow | 608,060 | 622,651 | 593,223 |
| Net Income | 445,053 | 421,362 | 410,351 |
| Net Change in Cash | -3,836 | 106,444 | 51,223 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2029 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 4,848,179.524 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 4,997,870.508 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 4,895,900 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | 1,051,373.576 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | 1,083,835.482 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | 1,061,722.213 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 1,125,908.128 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 1,171,233.527 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 1,140,357.495 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 2,130,997.372 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 2,196,793.429 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 2,151,972.711 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 15.710 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 16.140 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 15.510 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 5 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 2 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Strong Revenue Performance: ALGN has demonstrated consistent revenue growth as per historical income statements, supported by robust demand in the dental and orthodontic solutions market (evident from revenue product segments). This aligns with industry trends in the healthcare sector focusing on innovative dental technologies.
- Healthy Profitability Metrics: Key metrics such as gross profit margin TTM and net profit margin TTM indicate efficient cost management and strong profitability, positioning ALGN favorably against industry averages (industry_avg_priceToEarningsRatioTTM).
- Solid Cash Flow Generation: Positive free cash flow (as per cash flow statements) and a high free cash flow yield TTM reflect ALGN’s ability to generate cash for reinvestment or shareholder returns, underpinned by strong operating cash flow figures.
Log in with Full Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates ALGN intrinsic value between $122.17 – $239.86 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
Common questions about ALGN valuation
Is Align Technology, Inc. (ALGN) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Align Technology, Inc. (ALGN) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is ALGN a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether ALGN trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is ALGN’s P/E ratio?
You can see ALGN’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for ALGN?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is ALGN a good long-term investment?
Whether ALGN fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
ALGN
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-1.23
Trading Metrics:
| Open: | 168.52 | Previous Close: | 172.73 | |
| Day Low: | 164 | Day High: | 175.15 | |
| Year Low: | 122 | Year High: | 208.31 | |
| Price Avg 50: | 176.89 | Price Avg 200: | 159.42 | |
| Volume: | 1.074M | Average Volume: | 1.273M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeALGN full analysis
Welcome to MARKETSNAP’s SWOT analysis for Align Technology, the company behind some of the most innovative dental and orthodontic solutions out there, including the well-known Invisalign system. If you’re a long-term investor looking to sink your teeth into a company with a unique spot in the healthcare tech space, you’ve come to the right place. Today, we’re diving deep into Align Technology’s strengths, weaknesses, opportunities, and threats, while also unpacking recent performance, key financials, and what’s driving the stock. So,…
